RE:youtube has some bits about labssorry, not picking on Avant, it's a solid company cash flow + and I own that too but, that last q was really good for LABS much improved. I see them for sure hitting + adjusted ehbitda and cash flow + in 2024, like they're projecting. everything seems to be aligning just right.
VIVO buy was very shrewd for 8 million. Practically embarrassingly so. Abcann paid 133million for that , and we got it for 8. This might just be the very best buy in the industry. OGI looks great too.
whomever that was that did that 40-page report a while back hats off mate, It was amazing!